Related Experiment Videos
Protein crystallography and infectious diseases
C L Verlinde1, E A Merritt, F Van den Akker
1Department of Biological Structure, University of Washington, Seattle 98195.
Protein Science : a Publication of the Protein Society
|October 1, 1994
Summary
Structure-based drug design offers new therapeutic strategies. Protein structure analysis enables the development of novel drugs and vaccines targeting diseases like trypanosomiasis and cholera.
Area of Science:
- Structural Biology
- Medicinal Chemistry
- Drug Discovery
- Vaccine Development
Background:
- The growing database of 3D protein structures provides a foundation for designing new medical molecules.
- Insights from protein structure and function are crucial for developing treatments for various diseases.
- Structure-based design is a promising approach for creating novel therapeutics and vaccines.
Purpose of the Study:
- To illustrate the potential of structure-based drug design through two specific examples.
- To explore the development of antitrypanosomal drugs targeting glycolytic glycosomal enzymes.
- To investigate the design of anti-cholera drugs by analyzing cholera toxin and E. coli heat-labile enterotoxin structures.
Main Methods:
- Crystallographic studies
- Ligand-binding assays
- Molecular modeling
- Structural analysis of toxins
- Engineering of fusion proteins for vaccine design
Main Results:
- Demonstrated the feasibility of developing selective antitrypanosomal drugs.
- Identified strategies for anti-cholera drug design targeting toxin receptor binding or catalytic activity.
- Showcased the potential of engineered toxins for mucosal vaccine development.
Conclusions:
- Structure-based drug design holds significant promise for combating infectious diseases.
- Targeting pathogen-specific enzymes and toxins offers a route to selective therapeutic interventions.
- Protein structure analysis is key to advancing drug discovery and vaccine design.